Pharmacy Question for the Week of June 7, 2021

Question:

Are blood derivatives such as albumin infused for therapeutic treatment of liver failure or diseases such as cirrhosis billed as a biological by the pharmacy?

Answer:

Yes, understand that blood derivatives such as albumin infused for therapeutic treatment of liver failure or diseases such as cirrhosis or nephrotic syndrome resulting in hypoalbuminemia are billed as a biological by the pharmacy, and the administration of that substance is reported as drug administration, not blood transfusion.

Print Friendly, PDF & Email
Facebook
Twitter
LinkedIn

CPT® copyright 2023 American Medical Association (AMA). All rights reserved.

Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

CPT is a registered trademark of the American Medical Association.

Happy World Health Day! Our exclusive webcast, ‘2024 SDoH Update: Navigating Coding and Screening Assessment,’  is just $99 for a limited time! Use code WorldHealth24 at checkout.

SPRING INTO SAVINGS! Get 21% OFF during our exclusive two-day sale starting 3/21/2024. Use SPRING24 at checkout to claim this offer. Click here to learn more →